BRCA1 and BRCA2 Cancer Risks-Reference-Cited by-同舟云学术

BRCA1 and BRCA2 Cancer Risks

Published:2006-07-10 Issue:20 Volume:24 Page:3312-3313
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Antoniou Antonis C.¹,Pharoah Paul D.P.²,Easton Douglas F.³,Evans D. Gareth⁴

Affiliation:

1. Cancer Research United Kingdom Genetic Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

2. Cancer Research United Kingdom Human Cancer Genetics Group, Department of Oncology, University of Cambridge, Cambridge, United Kingdom

3. CR-UK Genetic Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

4. Academic Unit of Medical Genetics and Regional Genetics Service, St Mary's Hospital, Manchester, United Kingdom

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.06.7934

Reference7 articles.

1. Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample

2. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

3. Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers

4. On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance

5. The Genetic Epidemiology of Breast Cancer Genes

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex Hormones, Cancer, and Exercise Training in Women;Sex Hormones, Exercise and Women;2023

2. The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer Patients;The Oncologist;2022-09-16

3. Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates;Journal of Gynecologic Oncology;2017

4. Sex Hormones, Cancer and Exercise Training in Women;Sex Hormones, Exercise and Women;2016-11-11

5. Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil;Genetics and Molecular Biology;2016-05-24